Skip to main content
Erschienen in: Sleep and Biological Rhythms 4/2023

30.05.2023 | Original Article

Evaluation of emotional dysregulation in patients with restless legs syndrome

verfasst von: Hanife Kocakaya, Bahar Say

Erschienen in: Sleep and Biological Rhythms | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study is to examine patients with restless legs syndrome (RLS) in terms of difficulty in emotion regulation and insomnia. A total of 52 patients with RLS and 57 healthy volunteers were enrolled. Difficulties in Emotion Regulation Scale Short Form (DERS-16), Insomnia Severity Index (ISI), Hospital Anxiety and Depression Scale (HADS), and International Restless Legs Syndrome rating scale were applied to participants. The mean age was 34.00 ± 8.27 years in patients and 31.70 ± 9.12 years in control. The scores of DERS-16, ISI, HADS-A, and HADS-D were significantly higher in the patients than the controls (p = 0.000). The DERS-16 total score showed a significant correlation with age (r = 0.404, p = 0.003), ISI (r = 0.281, p = 0.043), IRLS score (r = 0.422, p = 0.002), HADS-A (r = 0.409, p = 0.003), and HADS-D (r = 0.416, p = 0.002). The factors (age, gender, ferritin, ISI, and IRLS scores) that may be associated with the DERS-16 total scores were assessed with stepwise regression analysis. It was seen that the IRLSs variable had the most ability and could predict 45% (β = 0.625, p < 0.001, ∆R2 = 0.450) of difficulty in emotion regulation. In addition, the variable of insomnia could predict difficulty in emotion regulation by 17% (β = 0.097, p = 0.001, ∆R2 = 0.170). Patients with RLS may experience more emotion regulation difficulties than healthy controls. RLS severity and insomnia may be factors affecting emotion regulation difficulties in patients with RLS. According to our knowledge and our literature review, this finding seems to be the first report in the literature.
Literatur
1.
Zurück zum Zitat Wijemanne S, Ondo W. Restless legs syndrome: clinical features, diagnosis and a practical approach to management. Pract Neurol. 2017;17(6):444–52.CrossRefPubMed Wijemanne S, Ondo W. Restless legs syndrome: clinical features, diagnosis and a practical approach to management. Pract Neurol. 2017;17(6):444–52.CrossRefPubMed
2.
Zurück zum Zitat Peeraully T, Tan EK. Linking restless legs syndrome with Parkinson’s disease: clinical, imaging and genetic evidence. Transl Neurodegener. 2012;1(1):1–6.CrossRef Peeraully T, Tan EK. Linking restless legs syndrome with Parkinson’s disease: clinical, imaging and genetic evidence. Transl Neurodegener. 2012;1(1):1–6.CrossRef
4.
Zurück zum Zitat Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, International Restless Legs Syndrome Study Group. Restless legs syndrome/Willis–Ekbom disease diagnostic criteria: updated international restless legs syndrome study group (IRLSSG) consensus criteria–history, rationale, description, and significance. Sleep Med. 2014;15(8):860–73.CrossRefPubMed Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, International Restless Legs Syndrome Study Group. Restless legs syndrome/Willis–Ekbom disease diagnostic criteria: updated international restless legs syndrome study group (IRLSSG) consensus criteria–history, rationale, description, and significance. Sleep Med. 2014;15(8):860–73.CrossRefPubMed
6.
Zurück zum Zitat Bonakis A, Androutsou A, Koloutsou ME, Vagiakis E. Restless Legs Syndrome masquerades as chronic insomnia. Sleep Med. 2020;75:106–11.CrossRefPubMed Bonakis A, Androutsou A, Koloutsou ME, Vagiakis E. Restless Legs Syndrome masquerades as chronic insomnia. Sleep Med. 2020;75:106–11.CrossRefPubMed
7.
Zurück zum Zitat Rottach KG, Schaner BM, Kirch MH, Zivotofsky AZ, Teufel LM, Gallwitz T, Messer T. Restless legs syndrome as a side effect of second-generation antidepressants. J Psychiatr Res. 2008;43(1):70–5.CrossRefPubMed Rottach KG, Schaner BM, Kirch MH, Zivotofsky AZ, Teufel LM, Gallwitz T, Messer T. Restless legs syndrome as a side effect of second-generation antidepressants. J Psychiatr Res. 2008;43(1):70–5.CrossRefPubMed
8.
Zurück zum Zitat Gross JJ. The emerging field of emotion regulation: an integrative review. Rev Gen Psychol. 1998;2(3):271–99.CrossRef Gross JJ. The emerging field of emotion regulation: an integrative review. Rev Gen Psychol. 1998;2(3):271–99.CrossRef
9.
Zurück zum Zitat Gratz KL, Roemer L. Multidimensional assessment of emotion regulation and dysregulation: development, factor structure, and initial validation of the difficulties in emotion regulation scale. J Psychopathol Behav Assess. 2004;26(1):41–54.CrossRef Gratz KL, Roemer L. Multidimensional assessment of emotion regulation and dysregulation: development, factor structure, and initial validation of the difficulties in emotion regulation scale. J Psychopathol Behav Assess. 2004;26(1):41–54.CrossRef
10.
Zurück zum Zitat Alcaro R, Huber J. Panksepp Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective. Brain Res Rev. 2007;56:283–321.CrossRefPubMedPubMedCentral Alcaro R, Huber J. Panksepp Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective. Brain Res Rev. 2007;56:283–321.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Yilmaz O, Şengül Y, Şengül HS, Parlakkaya FB, Öztürk A. Investigation of alexithymia and levels of anxiety and depression among patients with restless legs syndrome. Neuropsychiatr Dis Treat. 2018;14:2207.CrossRefPubMedPubMedCentral Yilmaz O, Şengül Y, Şengül HS, Parlakkaya FB, Öztürk A. Investigation of alexithymia and levels of anxiety and depression among patients with restless legs syndrome. Neuropsychiatr Dis Treat. 2018;14:2207.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Gruber R, Cassoff J. The interplay between sleep and emotion regulation: conceptual framework empiricalevidence and future directions. Curr Psychiatry Rep. 2014;16:500.CrossRefPubMed Gruber R, Cassoff J. The interplay between sleep and emotion regulation: conceptual framework empiricalevidence and future directions. Curr Psychiatry Rep. 2014;16:500.CrossRefPubMed
16.
Zurück zum Zitat Morin CM, Bastien CH, Vallieres A. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001;2:297–307.CrossRefPubMed Morin CM, Bastien CH, Vallieres A. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001;2:297–307.CrossRefPubMed
17.
Zurück zum Zitat Boysan M, Güleç M, ve Beşiroğlu L, Kalafat T. Uykusuzluk Şiddeti İndeksi’nin Türk örneklemindeki psikometrik özellikleri. Anadolu Psikiyatri Dergisi. 2010;11:248–52. Boysan M, Güleç M, ve Beşiroğlu L, Kalafat T. Uykusuzluk Şiddeti İndeksi’nin Türk örneklemindeki psikometrik özellikleri. Anadolu Psikiyatri Dergisi. 2010;11:248–52.
18.
Zurück zum Zitat Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.CrossRefPubMed Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.CrossRefPubMed
19.
Zurück zum Zitat Aydemir Ö, Güvenir T, Küey L. Ġty and realibility of Turkish version of hospital anxiety and depression scale. Turk J Psychiatry. 1997;8:280–7. Aydemir Ö, Güvenir T, Küey L. Ġty and realibility of Turkish version of hospital anxiety and depression scale. Turk J Psychiatry. 1997;8:280–7.
20.
Zurück zum Zitat Walters AS, Lebrocq C, Dhar A, et al. Validation of the international restless legs syndrome study group rating scale for restless legs syndrome. Sleep Med. 2003;4(2):121–32.CrossRefPubMed Walters AS, Lebrocq C, Dhar A, et al. Validation of the international restless legs syndrome study group rating scale for restless legs syndrome. Sleep Med. 2003;4(2):121–32.CrossRefPubMed
23.
Zurück zum Zitat Okita K, Ghahremani DG, Payer DE, Robertson CL, Dean AC, Mandelkern MA, London ED. Emotion dysregulation and amygdala dopamine D2-type receptor availability in methamphetamine users. Drug Alcohol Depend. 2016;161:163–70.CrossRefPubMedPubMedCentral Okita K, Ghahremani DG, Payer DE, Robertson CL, Dean AC, Mandelkern MA, London ED. Emotion dysregulation and amygdala dopamine D2-type receptor availability in methamphetamine users. Drug Alcohol Depend. 2016;161:163–70.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Salgado-Pineda P, Delaveau P, Blin O, Nieoullon A. Dopaminergic contribution to the regulation of emotional perception. Clin Neuropharmacol. 2005;28(5):228–37.CrossRefPubMed Salgado-Pineda P, Delaveau P, Blin O, Nieoullon A. Dopaminergic contribution to the regulation of emotional perception. Clin Neuropharmacol. 2005;28(5):228–37.CrossRefPubMed
25.
Zurück zum Zitat Seo D, Patrick CJ, Kennealy PJ. Role of serotonin and dopamine system interactions in the neurobiology of impulsive aggression and its comorbidity with other clinical disorders. Aggress Violent Beh. 2008;13(5):383–95.CrossRef Seo D, Patrick CJ, Kennealy PJ. Role of serotonin and dopamine system interactions in the neurobiology of impulsive aggression and its comorbidity with other clinical disorders. Aggress Violent Beh. 2008;13(5):383–95.CrossRef
27.
28.
Zurück zum Zitat Low RS, Overall NC, Chang VT, et al. Emotion regulation and psychological and physical health during a nationwide COVID-19 lockdown. Emotion. 2021;21:1671.CrossRefPubMed Low RS, Overall NC, Chang VT, et al. Emotion regulation and psychological and physical health during a nationwide COVID-19 lockdown. Emotion. 2021;21:1671.CrossRefPubMed
30.
Zurück zum Zitat Rinaldi F, Galbiati A, Marelli S, Cusmai M, Gasperi A, Oldani A, Ferini Strambi L. Defining the phenotype of restless legs syndrome/Willis–Ekbom disease (RLS/WED): a clinical and polysomnographic study. J Neurol. 2016;263(2):396–402.CrossRefPubMed Rinaldi F, Galbiati A, Marelli S, Cusmai M, Gasperi A, Oldani A, Ferini Strambi L. Defining the phenotype of restless legs syndrome/Willis–Ekbom disease (RLS/WED): a clinical and polysomnographic study. J Neurol. 2016;263(2):396–402.CrossRefPubMed
31.
Zurück zum Zitat Palagini L, Moretto U, Novi M, Masci I, Caruso D, Drake CL, Riemann D. Lack of resilience is related to stress-related sleep reactivity, hyperarousal, and emotion dysregulation in insomnia disorder. J Clin Sleep Med. 2018;14(5):759–66.CrossRefPubMedPubMedCentral Palagini L, Moretto U, Novi M, Masci I, Caruso D, Drake CL, Riemann D. Lack of resilience is related to stress-related sleep reactivity, hyperarousal, and emotion dysregulation in insomnia disorder. J Clin Sleep Med. 2018;14(5):759–66.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Mauss IB, Troy AS, LeBourgeois MK. Poorer sleep quality is associated with lower emotion-regulation ability in a laboratory paradigm. Cogn Emot. 2013;27:567–657.CrossRefPubMed Mauss IB, Troy AS, LeBourgeois MK. Poorer sleep quality is associated with lower emotion-regulation ability in a laboratory paradigm. Cogn Emot. 2013;27:567–657.CrossRefPubMed
33.
Zurück zum Zitat Gorman CA, Dyck PJ, Pearson JS. Symptom of restless legs. Arch Intern Med. 1965;115:155–60.CrossRefPubMed Gorman CA, Dyck PJ, Pearson JS. Symptom of restless legs. Arch Intern Med. 1965;115:155–60.CrossRefPubMed
35.
Zurück zum Zitat Chen MH, Su TP, Chen YS, Hsu JW, Huang KL, Chang WH, Bai YM. Association between psychiatric disorders and iron deficiency anemia among children and adolescents: a nationwide population-based study. BMC Psychiatry. 2013;13(1):1–8.CrossRef Chen MH, Su TP, Chen YS, Hsu JW, Huang KL, Chang WH, Bai YM. Association between psychiatric disorders and iron deficiency anemia among children and adolescents: a nationwide population-based study. BMC Psychiatry. 2013;13(1):1–8.CrossRef
Metadaten
Titel
Evaluation of emotional dysregulation in patients with restless legs syndrome
verfasst von
Hanife Kocakaya
Bahar Say
Publikationsdatum
30.05.2023
Verlag
Springer Nature Singapore
Erschienen in
Sleep and Biological Rhythms / Ausgabe 4/2023
Print ISSN: 1446-9235
Elektronische ISSN: 1479-8425
DOI
https://doi.org/10.1007/s41105-023-00467-z

Weitere Artikel der Ausgabe 4/2023

Sleep and Biological Rhythms 4/2023 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.